Swissmedic Highlights Updated MIR Template for Serious Incident Reporting Under MDR/IVDR

Swissmedic has published the updated Manufacturer Incident Report (MIR) template version 7.3.1 for reporting serious incidents under the European Medical Devices Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR). The revised template reflects the continued alignment of the European vigilance system with EUDAMED requirements and reinforces the use of standardized IMDRF coding across incident investigations.

The MIR form remains one of the most critical post-market surveillance and vigilance tools for manufacturers placing medical devices and IVDs on the European market. The updated version introduces additional structured fields and expanded reporting expectations that manufacturers should carefully review to ensure compliance readiness.

Key Elements Manufacturers Should Pay Attention To

The updated template reinforces the mandatory use of IMDRF adverse event terminology and coding throughout the reporting process, including:

  • Medical device problem codes

  • Clinical signs and health impact codes

  • Cause investigation findings and conclusions

  • Component-related coding

Manufacturers are also expected to provide more structured information regarding:

  • UDI and Basic UDI-DI identification

  • Device categorisation under MDR/IVDR

  • Market distribution details

  • Similar serious incident trending

  • Root cause investigation documentation

  • Corrective and preventive actions (CAPA)

  • Field Safety Corrective Actions (FSCA)

The form additionally requests more detailed information about device lifecycle status, including whether the device continues to be placed on the EU market after MDR/IVDR application dates, and whether consultation procedures involving EMA or expert panels apply to the device.

Increased Importance of Data Consistency

One notable aspect of version 7.3.1 is the stronger integration between vigilance reporting and EUDAMED data structures. Manufacturers should ensure that internal vigilance procedures, complaint handling systems, and PMS documentation are fully aligned with:

  • EUDAMED registrations

  • SRN and UDI information

  • IMDRF terminology

  • PMS and PMCF processes

  • FSCA documentation workflows

Inconsistencies between vigilance reports and technical documentation may increase scrutiny during competent authority reviews or notified body audits.

Impact on Manufacturers

For manufacturers, the updated MIR template may require revisions to existing vigilance procedures, internal reporting forms, and training programs. Companies relying on legacy complaint handling systems or manual coding processes may face additional operational challenges when preparing serious incident reports.

Manufacturers should also evaluate whether their current systems adequately support:

  • IMDRF coding integration

  • Trending analysis of similar incidents

  • Traceability of distributed devices

  • Structured CAPA documentation

  • Cross-functional vigilance coordination

As competent authorities continue to increase expectations regarding vigilance quality and reporting consistency, proactive adaptation to the updated MIR structure will be essential to maintain regulatory compliance under MDR and IVDR.

The updated MIR template version 7.3.1 is now available below.

Anterior
Anterior

ANVISA Publishes 2024–2025 Good Clinical Practice Inspection Metrics: What Clinical Trial Sponsors and Manufacturers Should Know

Próximo
Próximo

TGA Introduces Streamlined UDI Consent-to-Supply Pathway for Non-Compliant Medical Devices